OBJECTIVES: Human papillomavirus (HPV) infection is a major risk factor for cervical disease. Using baseline data from the HIV-infected cohort of Evandro Chagas Clinical Research Institute at Fiocruz, Rio de Janeiro, Brazil, factors associated with an increased prevalence of HPV were assessed. METHODS: Samples from 634 HIV-infected women were tested for the presence of HPV infection using hybrid capture II and polymerase chain reaction. Prevalence ratios (PR) were estimated using Poisson regression analysis with robust variance. RESULTS: The overall prevalence of HPV infection was 48%, of which 94% were infected with a high-risk HPV. In multivariate analysis, factors independently associated with infection with high-risk HPV type were: younger age (<30 years of age; PR 1.5, 95% confidence interval (CI) 1.1-2.1), current or prior drug use (PR 1.3, 95% CI 1.0-1.6), self-reported history of HPV infection (PR 1.2, 95% CI 0.96-1.6), condom use in the last sexual intercourse (PR 1.3, 95% CI 1.1-1.7), and nadir CD4+ T-cell count <100cells/mm(3) (PR 1.6, 95% CI 1.2-2.1). CONCLUSIONS: The estimated prevalence of high-risk HPV-infection among HIV-infected women from Rio de Janeiro, Brazil, was high. Close monitoring of HPV-related effects is warranted in all HIV-infected women, in particular those of younger age and advanced immunosuppression.
OBJECTIVES: Human papillomavirus (HPV) infection is a major risk factor for cervical disease. Using baseline data from the HIV-infected cohort of Evandro Chagas Clinical Research Institute at Fiocruz, Rio de Janeiro, Brazil, factors associated with an increased prevalence of HPV were assessed. METHODS: Samples from 634 HIV-infectedwomen were tested for the presence of HPV infection using hybrid capture II and polymerase chain reaction. Prevalence ratios (PR) were estimated using Poisson regression analysis with robust variance. RESULTS: The overall prevalence of HPV infection was 48%, of which 94% were infected with a high-risk HPV. In multivariate analysis, factors independently associated with infection with high-risk HPV type were: younger age (<30 years of age; PR 1.5, 95% confidence interval (CI) 1.1-2.1), current or prior drug use (PR 1.3, 95% CI 1.0-1.6), self-reported history of HPV infection (PR 1.2, 95% CI 0.96-1.6), condom use in the last sexual intercourse (PR 1.3, 95% CI 1.1-1.7), and nadir CD4+ T-cell count <100cells/mm(3) (PR 1.6, 95% CI 1.2-2.1). CONCLUSIONS: The estimated prevalence of high-risk HPV-infection among HIV-infectedwomen from Rio de Janeiro, Brazil, was high. Close monitoring of HPV-related effects is warranted in all HIV-infectedwomen, in particular those of younger age and advanced immunosuppression.
Authors: Mary C Cambou; José Eduardo Levi; Jordan E Lake; Angela de Andrade; Emilia M Jalil; Fabio Russomano; Mônica Derrico; Valdilea G Veloso; Ruth K Friedman; Paula M Luz; Beatriz Grinsztejn Journal: Int J Infect Dis Date: 2015-10-28 Impact factor: 3.623
Authors: Leomar D C Lyrio; Maria Fernanda R Grassi; Iuri U Santana; Viviana G Olavarria; Aline do N Gomes; Licia CostaPinto; Rone Peterson C Oliveira; Rita de Cássia R Aquino; Mittermayer B Santiago Journal: Rheumatol Int Date: 2012-03-27 Impact factor: 2.631
Authors: Corina R Lopez; Michael H Antoni; Deirdre Pereira; Julia Seay; Nicole Whitehead; Jonelle Potter; Maryjo O'Sullivan; Mary Ann Fletcher Journal: J Appl Biobehav Res Date: 2013-03-08
Authors: Bettina Moulin Coelho Lima; Jonathan E Golub; Adriana Tonani Mattos; Luciana Bueno de Freitas; Liliana Cruz Spano; Angélica Espinosa Miranda Journal: J Int Assoc Physicians AIDS Care (Chic) Date: 2009-08-31
Authors: Jacqueline Cortinhas Monteiro; Ricardo Roberto de Souza Fonseca; Tuane Carolina de Sousa Ferreira; Luana Lorena Silva Rodrigues; Andreza Reis Brasil da Silva; Samara Tatielle Gomes; Rodrigo Vellasco Duarte Silvestre; Andréa Nazaré Monteiro Rangel Silva; Ilze Pamplona; Antonio Carlos Rosário Vallinoto; Ricardo Ishak; Luiz Fernando Almeida Machado Journal: Front Public Health Date: 2021-04-29
Authors: Jordan E Lake; Ruth K Friedman; Cynthia B Cunha; Sandra W Cardoso; Valdilea G Veloso; Judith S Currier; Beatriz Grinsztejn Journal: HIV AIDS (Auckl) Date: 2011-07-01
Authors: Jessica L Castilho; José Eduardo Levi; Paula M Luz; Mary Catherine Cambou; Tazio Vanni; Angela de Andrade; Mônica Derrico; Valdiléa G Veloso; Beatriz Grinsztejn; Ruth K Friedman Journal: BMC Cancer Date: 2015-06-23 Impact factor: 4.430
Authors: Valeria Stuardo; Cristina Agustí; José Manuel Godinez; Alexandra Montoliu; Aureli Torné; Antoni Tarrats; Carmen Alcalde; Dolores Martín; Eulalia Fernández-Montoli; Cristina Vanrell; Josefa Solé; Yolanda Canet; José Manuel Marqueta; Jadiyettu Mohamed; Isabel Cuenca; Montserrat Lonca; Guillem Sirera; Elena Ferrer; Pere Domingo; Belen Lloveras; Josep María Miro; Silvia De Sanjosé; Jordi Casabona Journal: PLoS One Date: 2012-10-30 Impact factor: 3.240